Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Evofem Biosciences Inc (ID)
EVFM
Healthcare
Biotechnology
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. The company’s commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences...
, Inc. is headquartered in San Diego, California.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCID:EVFM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 01, 2022 8:47am
New Press Release - Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 "EVOGUARD" Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women
-- Top-line readout of data expected in October 2022 ---- U.S. regulatory submission planned for the first half of 2023 ---- Phexxi may become the first-ever woman-controlled prophylactic for the prevention of chlamydia and gonorrhea --SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- Evofem Biosciences...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 29, 2022 8:24am
New Press Release - Evofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to Individuals
SAN DIEGO, July 29, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM), a women's healthcare company, today commended the U.S. Department of Health and Human Services, alongside the Departments of Labor and of the Treasury ("the Tri-Agencies"), for taking action to clarify protections...
read article.
Scaling for long-term success: A new era in gold development
posted Dec 11, 2025 9:00am by
Vista Gold Corp.
-
|
Backed by years of technical expertise and strategic discipline, Mt Todd has emerged as one of the most compelling undeveloped gold assets globally. A recently completed feasibility study signals a pivotal shift in strategy ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 28, 2022 8:47am
New Press Release - Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022
-- Conference Call Scheduled for 5:00 p.m. ET --SAN DIEGO, July 28, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the second quarter ended June 30, 2022 as follows:Date:Thursday...
read article.
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 26, 2022 3:30pm
EVFM ..... Buying the dip is a good thing ; )
Tomorrow just could be a reversal....jmho Cheers !
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 26, 2022 8:48am
New Press Release - Evofem's House Rules Campaign Featuring Annie Murphy Receives Significant Industry Recognition
Evocative direct-to-consumer (DTC) campaign has received 12 healthcare and communications industry awards to date and has recently been shortlisted for four more awards. The national campaign features Emmy® Award-winning spokeswoman and actress Annie Murphy and was created to generate awareness...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 25, 2022 8:47am
New Press Release - Evofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive Counseling
SAN DIEGO, July 25, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has developed a new educational birth control chart that provides high-level information about the different options available to women in the United States."Contraceptive counseling is one of the...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 22, 2022 8:47am
New Press Release - Evofem Biosciences Applauds U.S. House of Representatives for Passing The Right to Contraception Act
SAN DIEGO, July 22, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM), a women's healthcare company, today applauded the 228 members of the U.S. House of Representatives who voted to pass legislation to safeguard access to contraceptives entitled The Right to Contraception Act."Today...
read article.
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 21, 2022 12:12pm
EVFM ....How do u like me so far?
Ka F'ing Boom !!!! Cheers !
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 21, 2022 11:47am
EVFM....... Boom.... NR this a.m !
The H.O.D this a.m was $1.04.....currently in PB mode at $0.96 I firmly believe we will see much higher #'s in the coming weeks.... My ultimate target would be to see a break of $1.50 .... JMHO
...more
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 20, 2022 11:20am
EVFM.....screw it..... I'm in here at.....
84.....Cheers !
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 19, 2022 2:23pm
EVFM.... I would be a buyer on weakness
Currently at $0.81.....target buy would be $0.75 Cheers !
(17)
•••
leclad5
X
Comment by
leclad5
on Mar 18, 2021 9:58am
RE:FDA APPROVED
pretty sad that almost a year later right back where we started
(2)
•••
bolander
X
Post by
bolander
on Jun 23, 2020 8:16pm
FDA APPROVED
With Phexxi recently FDA approved we should see upward movement~ today $2.87 a good entry price..
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Lode Gold Enters into Exclusive LOI with a Mining Company to Advance Fremont Gold Project
Mt Todd has emerged as one of the most compelling undeveloped gold assets globally